Manuela Dr. med Niewel

Manuela Dr. med Niewel has a wealth of experience in the pharmaceutical industry, with a focus on clinical development and oncology. Manuela is currently serving as the Chief Medical Officer at Peptomyc since October 2019. Prior to that, they worked as a Medical Consultant Clinical Development at T-knife, Immunicum AB, and MonTa Biosciences from January 2019 to October 2019. Manuela also held the position of Senior Vice President Clinical Development at Rigontec GmbH from 2015 until 2018. Before joining Rigontec, they worked as the Medical Director, Oncology at Chiltern from 2013 to 2015. From 2003 to 2012, they served as the Senior Medical Director Oncology, Europe and ROW at PharmaNet/i3. Manuela's career started in 1998 when they held the role of Chief Scientific Officer at Oncology Services GMBH.

Manuela Dr. med Niewel obtained a degree in Medicine from the Technical University of Munich in 1988. Manuela holds the title of Dr. med. during this time. Additionally, they hold a Diploma of Pharmaceutical Medicine from DGPharMed, although the start and end years for this qualification are not provided.